Factors Fueling Patients' Mistrust
A growing mistrust of medical providers could be traced back to doubts about scientific validity and treatment costs, according to Luke Hansen, M.D., M.H.S., chief medical officer of Arcadia, a healthcare data analytics company.
Americans’ trust in physicians and hospitals plummeted 31% after the COVID-19 pandemic, falling from 71.5% in April 2020 to 40.1% in January 2024, according to a study published in JAMA Network Open in August 2024.
Luke Hansen, M.D., M.H.S.
“Erosion of trust in the industry overall, specifically in the providers, is really dangerous,” Luke Hansen, M.D., M.H.S., chief medical officer of Arcadia, said in a video interview with Managed Healthcare Executive. “In some ways, I think it’s a response to the larger questioning of scientific validity that's occurring. People might also have financial stress because of their healthcare condition that translates to their provider.”
Hansen went on to explain how patients’ distrust can lead to treatment challenges.
“Fundamental to chronic disease management is behavior change,” he said. “If a patient who has no symptoms of their chronic disease is going to do the right thing, they need to trust whoever is telling them to do the right thing,” he said. “That’s something biological that we're fighting against in human nature.”
Phase 3 Trial of Vertex’s Islet Cell Therapy for Type 1 Diabetes in Under Way
April 23rd 2025Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if approved, would be the second cell therapy for type 1 diabetes.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Experts Explore Causes and Care for Chronic Itch
April 22nd 2025In a recent discussion with Managed Healthcare Executive, three leading dermatologists and itch experts—Shawn Kwatra, M.D., Brian Kim, M.D., and Gil Yosipovitch, M.D.—shared where the science is going, what’s holding it back and how the healthcare system can better support patients.
Read More
